Accompanying the aging of populations worldwide, and increased survival with chronic
diseases, the incidence and prevalence of atrial fibrillation (AF) are rising, justifying the term …

Despite remarkable advances in antiarrhythmic drugs, ablation procedures, and stroke-
prevention strategies, atrial fibrillation (AF) remains an important cause of death and …

Atrial fibrillation (AF) is the most common cardiac arrhythmia; the lifetime risk is 1 in 4 for
persons over the age of 40 years in the United States. 1 AF is associated with an increased …

The global prevalence of atrial fibrillation (AF) has increased substantially over the past
three decades and is currently approximately 60 million cases. Incident AF and its clinical …

Atrial fibrillation (AF) has heterogeneous patterns of presentation concerning symptoms,
duration of episodes, AF burden, and the tendency to progress towards the terminal step of …

Atrial fibrillation (AF) is the most common arrhythmia (estimated lifetime risk, 22%–26%). The
aim of this article is to review the clinical epidemiological features of AF and to relate them to …

Atrial fibrillation (AF) is an epidemic, affecting 1% to 1.5% of the population in the developed
world. Projected data from the population‐based studies suggest that the prevalence of AF …

There is increasing awareness that management of atrial fibrillation (AF) and its
complications (particularly strokes) constitutes an important burden for health care systems …

Machine learning applications in cardiology have rapidly evolved in the past decade. With
the availability of machine learning tools coupled with vast data sources, the management of …

There has been an exponential growth of artificial intelligence (AI) and machine learning
(ML) publications aimed at advancing our understanding of atrial fibrillation (AF), which has …